Business Description
Actinium Pharmaceuticals is a New York-based company focused on developing targeted radiation treatments for patients with cancer and other serious blood disorders, particularly those who have not responded to standard therapies. Its pipeline includes treatments for acute myeloid leukemia, prostate cancer, and conditions like sickle cell disease, as well as a conditioning agent designed to improve the safety and success of bone marrow transplants. The company also works alongside the National Cancer Institute to advance several of its programs and continues to explore new treatment options for solid tumors.
